USA, Rockville MD, Aug. 16, 2022 (GLOBE NEWSWIRE) — In 2022, the global blood gas and electrolyte analyzer market is worth US$4.2 billion in revenue and is expected to grow at a CAGR of 5.6% 2030.
The growing attention to health care across the world has led to an increase in medical tourism, which is expected to foster Blood Gas and Electrolyte Analyzer Market potential in the years to come. Rising aging population, advancements in technology, and increasing patient population in critical care facilities are other factors that will drive the growth of the blood gas and electrolyte analyzer market.
For critical information on Blood gas and electrolyte analyzers Market, demand a Sample report
This new study from Fact.MR, a market research and competitive intelligence provider, profiled prominent players such as Radiometer Medical ApS., EKF Diagnostics, Abbott Point of Care Inc., ERBA Diagnostics Manheim GmbH, Alere Inc., Werfen, Erba Mannheim, Cornley Hi-tech Co. Ltd., EDAN Instruments Inc., F. Hoffman La Roche and Fortress Diagnostics.
What is To increase the growth of the Blood Gas and Electrolyte Analyzers market?
“Rising incidence of diabetes and blood disorders worldwide”
The prevalence of blood disorders and chronic diseases has increased over the past few years and this trend is also expected to continue during the forecast period.
The above-mentioned factors have led to a high demand for blood tests and are therefore expected to drive sales of blood gas and electrolyte analyzers over the next eight years.
Diabetes requires continuous blood monitoring, which is also expected to drive the market potential of blood gas and electrolyte analyzers. The growing number of diagnostic procedures requiring blood analysis and testing is also expected to positively influence the market potential of blood gas and electrolyte analyzers through 2030.
To learn more about Blood gas and electrolyte analyzers Market, you can contact our analyst at https://www.factmr.com/connectus/sample?flag=AE&rep_id=5126
Key segments covered by the Blood gas and electrolyte analyzers Industry survey
- By product type:
- Electrolyte Analyzers
- Combined Analyzers
- Blood gas analyzers
- By Modality:
- Per end user:
- point of service
- Diagnostic centers
- Clinical laboratories
- Other end users
- By region:
- North America
- Latin America
Manufacturers of blood gas and electrolyte analyzers should focus on developing and launching advanced new products to gain a competitive advantage over other market players and strengthen their presence in the market.
- In July 2022, EDAN Instruments Inc., an organization dedicated to providing quality medical products, announced the launch of a new blood gas analysis system. i20 is a new point-of-care (POC) fluorescence-based CO-OX blood gas and chemistry analysis solution designed to relieve the burden of intensive care units (ICU), operating rooms , etc.
The blood gas and electrolyte analyzer market players are expected to focus on advancing their research and development to accelerate the launch of new products. Manufacturers should also focus on integrating advanced technologies to improve the efficiency of their product offerings.
Get customization on Blood gas and electrolyte analyzers Market Report for specific search solutions
The key players in the Blood gas and electrolyte analyzers Market
- Siemens Health
- Radiometer Medical ApS.
- EKF diagnosis
- Cornley Hi-tech Co. Ltd.
- Edan Instruments Inc.
- Abbott Point of Care Inc.
- Diagnosis ERBA Manheim GmbH
- Alère Inc.
Main takeaways from Blood gas and electrolyte analyzers Market research
- Currently, the global blood gas and electrolyte analyzer market is valued at US$4.2 billion.
- From 2022 to 2030, sales of blood gas and electrolyte analyzers are expected to increase by 5.6% CAGR.
- By 2030, the market is expected to be valued at US$6.5 billion.
- Rising incidence of blood disorders, growing geriatric population, increasing investment in healthcare infrastructure development and increasing use of blood tests in various diagnostic procedures are factors propelling the growth of the market.
- The high costs of analyzers and the complexity of interpreting blood test data are expected to have a negative effect on the overall market potential.
- The wearable segment is expected to grow at a CAGR of 5% throughout the forecast period.
Explore Fact.MR’s Healthcare coverage-
Patient Positioning System Market– In 2020, the global patient positioning systems market was valued at US$1 billion and is projected to grow nearly US$500 million by the end of 2031.
Dermatology Devices Market– The global dermatology devices market revenue reached US$12 billion in 2020, and the market is expected to reach US$39 billion by 2031.
Medical Case Management Services Market– The global market for medical case management services. Analysts predicted the industry would grow at a stagnant CAGR of around 3.2% over the decade.
Over-the-Counter (OTC) Painkillers Market– Global Over-the-Counter Analgesics Market was valued at approximately US$25 Billion in 2020 and is projected to accelerate at a CAGR of 5% through 2031. The demand for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is expected to grow at a CAGR of 4% over the evaluation period from 2021 to 2031.
Hemostasis Diagnostics market– According to the latest industry analysis on hemostasis diagnostics by Fact.MR, the global market was valued at around US$2 billion in 2020, and is expected to accelerate at a CAGR of 7% to double in valuation and reach US$4 billion by 2031.
liver cancer diagnostics market– This revised research analysis on liver cancer market by qualified analysts at Fact.MR predicts the industry to grow at a healthy CAGR of 8.2% over the next ten years.
breathalyzer market– The global breathalyzer market was valued at around US$760 million in 2020, accounting for around 13% of the overall drug testing market. Breathalyzer sales are expected to accelerate at a steady CAGR of 8% to reach US$1.7 billion by 2031.
Spine Devices Market– The global spine devices market revenue was recorded at US$11 billion in 2020 and is expected to grow 1.5x by the end of the decade. These results are from a revised analysis by Fact.MR, a market research and competitive intelligence provider.
Urinary Tract Infection Treatment Market– Global Urinary Tract Infection Treatment Market was valued at USD 10.5 Billion in 2021 and is projected to grow at a CAGR of 2.1% to reach USD 12.9 Billion by 2031.
Flat Panel Detector Based X-rays for the Cone Beam CT Market– The global market for X-rays based on flat-panel detectors for cone-beam computed tomography (FPD-based X-rays for CBCT) is expected to reach US$3.2 billion in 2022, and is expected to grow at over 7% CAGR for reach US$6.3 billion by the end of the 2022-2032 assessment period.
Market research and consulting agency that makes the difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. Although our experienced consultants use the latest technology to extract hard-to-find information, we believe that our USP is the trust our clients place in our expertise. Covering a wide spectrum – from automotive and Industry 4.0 to healthcare and retail, our coverage is extensive, but we ensure that even the most niche categories are analyzed. Our sales offices in the USA and Dublin, Ireland. Headquarters based in Dubai, United Arab Emirates. Contact us with your goals and we will be a competent research partner.
USA Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Email: [email protected]
Tel: +1 (628) 251-1583
Follow us: LinkedIn | Twitter